Table 2 CSF cytokine levels for all patients and by amyloid group
From: Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
All (n = 111) | A- (n = 49) | A+ (n = 62) | P | |
|---|---|---|---|---|
Continuous markers (pg/mL), median (Q1; Q3)a | ||||
Eotaxin-1 | 3.95 (3.27; 4.72) | 3.93 (3.48; 4.72) | 3.97 (3.16; 4.49) | 0.73 |
G-CSF | 15.75 (6.37; 27.94) | 11.79 (5.16; 29.2) | 16.24 (8.33; 25.91) | 0.46 |
IL-6 | 1.51 (1.00; 2.31) | 1.44 (1.09; 2.45) | 1.54 (1.00; 2.06) | 0.58 |
IL-8 | 20.59 (17.58; 25.44) | 20.58 (18.11; 25.12) | 20.66 (17.33; 25.44) | 0.54 |
IP-10 | 1740 (1333; 2196) | 1845 (1333; 2205) | 1652 (1342; 2118) | 0.49 |
MCP-1 | 153.87 (127.44; 177.55) | 142.39 (127.44; 177.34) | 154.64 (129.57; 177.72) | 0.61 |
MIP-1α | 0.33 (0.2; 0.42) | 0.31 (0.17; 0.40) | 0.34 (0.23; 0.49) | 0.10 |
Dichotomised markers, n (% detected)b | ||||
MIP-1β | 34 (30.63) | 16 (32.65) | 18 (29.03) | 0.68 |
IL-7 | 40 (36.04) | 17 (34.69) | 23 (37.10) | 0.79 |